Evidence map›Paper›PMID 31524503›Full record

ArticleAmerican journal of respiratory and critical care medicine2020

Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease.

Shehabaldin Alqalyoobi, Ayodeji Adegunsoye, Angela Linderholm, Cara Hrusch, Claire Cutting, Shwu-Fan Ma, Anne Sperling, Imre Noth, Mary E Strek, Justin M Oldham

Abstract readLetter
In one paragraph

Article in American journal of respiratory and critical care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Prognostic biomarkers for the development of progressive pulmonary fibrosis in hypersensitivity pneumonitis: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  2. Article
  3. Prevalence and Prognostic Impact of Progressive Pulmonary Fibrosis.Tuberculosis and respiratory diseases · 2026
    Review
  4. Immunological mechanisms and therapeutic approaches in pulmonary fibrosis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  5. Article
  6. Proteomic Biomarkers of Survival in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease.American journal of respiratory and critical care medicine · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. INTEGRIS-IPF: A New Hope for Tomorrow.American journal of respiratory and critical care medicine · 2024
    Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.Annals of the American Thoracic Society · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shehabaldin AlqalyoobiUniversity of California, DavisSacramento, California.ORCID 0000-0001-5602-2725
Ayodeji AdegunsoyeUniversity of ChicagoChicago, Illinois.
Angela LinderholmUniversity of California, DavisSacramento, California.
Cara HruschUniversity of ChicagoChicago, Illinois.
Claire CuttingUniversity of California, DavisSacramento, California.
Shwu-Fan MaUniversity of VirginiaCharlottesville, Virginiaand.
Anne SperlingUniversity of ChicagoChicago, Illinois.
Imre NothUniversity of VirginiaCharlottesville, Virginiaand.
Mary E StrekUniversity of ChicagoChicago, Illinois.
Justin M OldhamUniversity of California, DavisSacramento, California.

Funding

Architectural structure and regulation of TOLLIP in IPFR01HL130796 · NHLBI · UNIVERSITY OF VIRGINIA · PI NOTH, IMRE · 2016 to 2019
$3.1M
Elucidating the Genomic Determinants of Outcomes in Idiopathic Pulmonary FibrosisK23HL138190 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OLDHAM, JUSTIN M · 2017 to 2021
$914k
NHLBI NIH HHS K23 HL138190NHLBI NIH HHS R01 HL130796
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAlveolitis, Extrinsic AllergicBiomarkersCA-125 AntigenChemokine CXCL13Chitinase-3-Like Protein 1Connective Tissue DiseasesDisease ProgressionFemaleHumansLung Diseases, InterstitialLung TransplantationMaleMatrix Metalloproteinase 7Middle AgedPrognosisBiomarkersCA-125 AntigenChemokine CXCL13CHI3L1 protein, humanChitinase-3-Like Protein 1Matrix Metalloproteinase 7Pulmonary Surfactant-Associated Protein DVascular Cell Adhesion Molecule-1

Identifiers

PMID31524503
PMCPMC6961741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.